Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RGC · against 330 other Healthcare companies of similar size
Ranked #258 of 331 · scores higher than 22% of peers · safety percentile 24
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)30 peers with a safety percentile of 20–29, including RGC · Click a bar to see the companies
Mainly because of its beta and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RGC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 319 reported | 0.32× | 0.24× | 42% | 33% | |
| BetaLower is better · 317 reported | 1.43 | 0.58 | 14% | 33% | |
| Current ratioHigher is better · 318 reported | 1.42× | 2.84× | 18% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 254 | 1.3B CHF (≈$1.5B) | 25 | 48 | |
| 255 | 2.0B USD | 25 | 26 | |
| 256 | 73.5B TRY (≈$2.2B) | 24 | 68 | |
| 257 | 3.4B EUR (≈$3.7B) | 24 | 64 | |
| 258 | 3.0B USD | 24 | 11 | |
| 259 | 1.7B EUR (≈$1.9B) | 24 | 58 | |
| 260 | 15.4B HKD (≈$2.0B) | 23 | 44 | |
| 261 | 3.4B USD | 23 | 17 | |
| 262 | 4.0B USD | 23 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score